{"retracted":false,"update":{"timestamp":1488326400000,"doi":"10.1136/annrheumdis-2014-207178corr1","type":"correction"},"doi":"10.1136/annrheumdis-2014-207178","journal":"Annals of the Rheumatic Diseases","publisher":"BMJ","title":"n Erratum:n Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biologic diseasemodifying antirheumatic drugsn "}
